Author:
Alavi-Moghadam Sepideh,Kokabi-Hamidpour Shayesteh,Rezaei-Tavirani Mostafa,Larijani Bagher,Arjmand Rasta,Rahim Fakher,Rezazadeh-Mafi Ahmad,Adibi Hossein,Arjmand Babak
Reference18 articles.
1. Ai J, Kiasat-Dolatabadi A, Ebrahimi-Barough S et al (2014) Polymeric scaffolds in neural tissue engineering: a review. Arch Neurosci 1(1):15–20
2. Rahim F, Arjmand B (2017) Stem cell clinical trials for multiple sclerosis: the past, present and future. In: Neurological Regeneration. Springer, pp. 159–172
3. Moghaddam SA, Yousefi B, Sanooghi D et al (2017) Differentiation potential of human CD133 positive hematopoietic stem cells into motor neuron-like cells, in vitro. J Chem Neuroanat 86:35–40
4. Arjmand B, Roudsari PP, Alavi-Moghadam S et al (2021) Potential for stem cell-based therapy in the road of treatment for neurological disorders secondary to COVID-19. In: Regenerative engineering and translational medicine, pp. 1–15
5. Derakhshanrad N, Saberi H, Meybodi KT et al (2015) Case report: combination therapy with mesenchymal stem cells and granulocyte-colony stimulating factor in a case of spinal cord injury. Basic Clin Neurosci 6(4):299